Satow Tetsu, Ishii Daizo, Iihara Koji, Sakai Nobuyuki
Neurol Med Chir (Tokyo). 2014;54 Suppl 2:98-106.
In treating ruptured vertebral artery dissecting aneurysms (VADAs), neuroendovascular therapy (NET) represented by coil obliteration is considered to be a reliable intervention. However, there has been no multi-center based study in this setting so far. In this article, results of NET for ruptured VADA obtained from Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2 were assessed to elucidate the factors associated with favorable outcome. A total of 213 in JR-NET1 and 381 patients in JR-NET2 with ruptured VADA were included, and they were separately analyzed because several important datasets such as vasospasm and site of dissecting aneurysms in relation to the posterior inferior cerebellar artery (PICA) were collected only in JR-NET1. The ratio of poor World Federation of Neurosurgical Societies (WFNS) grade (4 and 5) was 48.8% and 53.9%, and the ratio of favorable outcome (modified Rankin scale, mRS 0 to 2) at 30 days after onset was 61.1 % and 49.1% in JR-NET1 and 2, respectively. In both studies, poor WFNS grade and procedural complication were independently correlated as negative factors for favorable outcome. In JR-NET1, PICA-involved lesion was also designated as a negative factor while elderly age and absence of postprocedural antithrombotic therapy was detected as other negative factors in JR-NET2. The ratios of favorable outcome in poor grade patients were 25.4% in JR-NET1 and 31.3% in JR-NET2, which seemed compatible with the previous studies. These results may provide a baseline data for the NET in this disease and could be useful for validating the benefits of novel devices.
在治疗破裂性椎动脉夹层动脉瘤(VADA)时,以弹簧圈栓塞为代表的神经血管内治疗(NET)被认为是一种可靠的干预手段。然而,目前尚无基于多中心的相关研究。在本文中,对日本神经血管内治疗注册研究(JR-NET)1和2中破裂性VADA的NET治疗结果进行了评估,以阐明与良好预后相关的因素。JR-NET1中共纳入213例破裂性VADA患者,JR-NET2中纳入381例,由于一些重要数据集(如血管痉挛以及夹层动脉瘤与小脑后下动脉(PICA)的位置关系)仅在JR-NET1中收集,因此对两组患者分别进行了分析。神经外科医师协会世界联合会(WFNS)低分级(4级和5级)的比例在JR-NET1中为48.8%,在JR-NET2中为53.9%,发病后30天时良好预后(改良Rankin量表,mRS 0至2)的比例在JR-NET1中为61.1%,在JR-NET2中为49.1%。在两项研究中,WFNS低分级和手术并发症均作为良好预后的独立负性因素相关联。在JR-NET1中,累及PICA的病变也被确定为负性因素,而在JR-NET2中,高龄和术后未进行抗栓治疗被检测为其他负性因素。低分级患者中良好预后的比例在JR-NET1中为25.4%,在JR-NET2中为31.3%,这似乎与先前的研究结果相符。这些结果可为该疾病的NET治疗提供基线数据,并有助于验证新型器械的疗效。